Literature DB >> 25296902

Long-term outcome of chronic myeloid leukaemia patients with p210 and p190 co-expression at baseline.

Matteo Molica1, Irene Zacheo, Daniela Diverio, Giuliana Alimena, Massimo Breccia.   

Abstract

Entities:  

Keywords:  chronic myeloid leukaemia; imatinib; interferon; p190; prognosis

Mesh：

Substances：

Year:  2014        PMID： 25296902     DOI： 10.1111/bjh.13184

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.

Authors:  Markus Pfirrmann; Dobromira Evtimova; Susanne Saussele; Fausto Castagnetti; Francisco Cervantes; Jeroen Janssen; Verena S Hoffmann; Gabriele Gugliotta; Rüdiger Hehlmann; Andreas Hochhaus; Joerg Hasford; Michele Baccarani
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-12       Impact factor: 4.553

2.  Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Authors:  Shady Adnan-Awad; Daehong Kim; Helena Hohtari; Komal Kumar Javarappa; Tania Brandstoetter; Isabella Mayer; Swapnil Potdar; Caroline A Heckman; Soili Kytölä; Kimmo Porkka; Eszter Doma; Veronika Sexl; Matti Kankainen; Satu Mustjoki
Journal:  Leukemia       Date:  2020-11-09       Impact factor: 11.528

3.  Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.

Authors:  Samara Silveira da Cruz; Aline Damasceno Seabra; Lais Helena Rescinho Macambira; Débora Monteiro Carneiro; Patrícia Ferreira Nunes; Thais Brilhante Pontes; Fernando Augusto Rodrigues Mello-Junior; Lucyana Barbosa Cardoso Leão; Fernanda de Nazaré Cardoso Dos Santos Cordeiro; Thiago Xavier Carneiro; Caroline Aquino Moreira-Nunes; Rommel Mario Rodríguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.096

Review 4.  Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia.

Authors:  Matteo Molica; Elisabetta Abruzzese; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.